118 related articles for article (PubMed ID: 9088372)
1. The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain.
von Holst H; Nygren C; Boström K; Collins VP; Fredman P
Acta Neurochir (Wien); 1997; 139(2):141-5. PubMed ID: 9088372
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo.
Wikstrand CJ; He XM; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD
J Neuropathol Exp Neurol; 1991 Nov; 50(6):756-69. PubMed ID: 1748882
[TBL] [Abstract][Full Text] [Related]
3. Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
Piao H; Kuan CT; Chandramohan V; Keir ST; Pegram CN; Bao X; Månsson JE; Pastan IH; Bigner DD
MAbs; 2013; 5(5):748-62. PubMed ID: 23924792
[TBL] [Abstract][Full Text] [Related]
4. Expression of gangliosides GD3 and 3'-isoLM1 in autopsy brains from patients with malignant tumors.
Fredman P; von Holst H; Collins VP; Dellheden B; Svennerholm L
J Neurochem; 1993 Jan; 60(1):99-105. PubMed ID: 8417168
[TBL] [Abstract][Full Text] [Related]
5. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains.
Hedberg KM; Mahesparan R; Read TA; Tysnes BB; Thorsen F; Visted T; Bjerkvig R; Fredman P
Neuropathol Appl Neurobiol; 2001 Dec; 27(6):451-64. PubMed ID: 11903928
[TBL] [Abstract][Full Text] [Related]
6. GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice.
Kato Y; Kuan CT; Chang J; Kaneko MK; Ayriss J; Piao H; Chandramohan V; Pegram C; McLendon RE; Fredman P; Månsson JE; Bigner DD
Biochem Biophys Res Commun; 2010 Jan; 391(1):750-5. PubMed ID: 19944071
[TBL] [Abstract][Full Text] [Related]
7. Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.
Wikstrand CJ; Fredman P; Svennerholm L; Bigner DD
Prog Brain Res; 1994; 101():213-23. PubMed ID: 7518092
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro.
Wikstrand CJ; Fredman P; McLendon RR; Svennerholm L; Bigner DD
Mol Chem Neuropathol; 1994; 21(2-3):129-38. PubMed ID: 7522005
[TBL] [Abstract][Full Text] [Related]
9. Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors.
Fredman P
Prog Brain Res; 1994; 101():225-40. PubMed ID: 8029453
[TBL] [Abstract][Full Text] [Related]
10. Sialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas.
Fredman P; von Holst H; Collins VP; Granholm L; Svennerholm L
J Neurochem; 1988 Mar; 50(3):912-9. PubMed ID: 3339365
[TBL] [Abstract][Full Text] [Related]
11. Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
Wikstrand CJ; Longee DC; McLendon RE; Fuller GN; Friedman HS; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1993 Jan; 53(1):120-6. PubMed ID: 8416736
[TBL] [Abstract][Full Text] [Related]
12. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors.
Sung CC; Pearl DK; Coons SW; Scheithauer BW; Johnson PC; Yates AJ
Cancer; 1994 Dec; 74(11):3010-22. PubMed ID: 7954264
[TBL] [Abstract][Full Text] [Related]
13. Expression of the GM1-species, [NeuN]-GM1, in a case of human glioma.
Fredman P; Månsson JE; Dellheden B; Boström K; von Holst H
Neurochem Res; 1999 Feb; 24(2):275-9. PubMed ID: 9972875
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to malignant human gliomas.
Wikstrand CJ; Fredman P; Svennerholm L; Humphrey PA; Bigner SH; Bigner DD
Mol Chem Neuropathol; 1992 Oct; 17(2):137-46. PubMed ID: 1384525
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides in human fetal brain.
Svennerholm L; Rynmark BM; Vilbergsson G; Fredman P; Gottfries J; Månsson JE; Percy A
J Neurochem; 1991 May; 56(5):1763-8. PubMed ID: 2013764
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside profiles in human gliomas: quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading.
Wagener R; Röhn G; Schillinger G; Schröder R; Kobbe B; Ernestus RI
Acta Neurochir (Wien); 1999; 141(12):1339-45. PubMed ID: 10672306
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of ganglioside GD3 in neoplastic astrocytes. An immunocytochemical study in humans.
Kawai K; Takahashi H; Watarai S; Ishizu H; Fukai K; Tanabe Y; Nose S; Kuroda S
Virchows Arch; 1999 Mar; 434(3):201-5. PubMed ID: 10190298
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of gangliosides in ENU-induced rat glioma.
Takeshima F; Iwasaki K; Shimokawa I; Ikeda T; Matsuo T
Acta Pathol Jpn; 1992 Aug; 42(8):558-65. PubMed ID: 1449052
[TBL] [Abstract][Full Text] [Related]
19. Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.
Fabris D; Rožman M; Sajko T; Vukelić Ž
Biochimie; 2017 Jun; 137():56-68. PubMed ID: 28286312
[TBL] [Abstract][Full Text] [Related]
20. Determination of gangliosides in six human primary medulloblastomas.
Gottfries J; Fredman P; Månsson JE; Collins VP; von Holst H; Armstrong DD; Percy AK; Wikstrand CJ; Bigner DD; Svennerholm L
J Neurochem; 1990 Oct; 55(4):1322-6. PubMed ID: 2398361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
